Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen Immunogenicity in Adult GHD
NCT01237340Phase 3Terminated
- Sponsor
- EMD Serono
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), sponsored by EMD Serono. Started Oct 2010; status: terminated.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01237340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01237340.